GT Biopharma, Inc.GTBPNASDAQ
Loading
Revenue CAGR (5Y)
—
Margin Trend
stable
Free Cash Flow
($0.0B)
Profitability
Unprofitable
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Income | -58 | -21 | -14 |
| Net Income | -58 | -21 | -8 |
| EBITDA | -57 | -21 | 6 |
| EPS Diluted | -2.06 | -0.66 | -5.64 |
1 / 2
Values in millions except EPS · Ratios shown as percentages